Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)

Avalo Therapeutics (AVTX) has 10 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 16.96% year-over-year to 0.0; the trailing twelve-month figure through Dec 2025 stood at 0.0 (up 16.96% YoY), and the FY2025 full-year result was 0.0, down 91.4% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.0, up from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.56 in Q2 2023 and bottomed at 0.0 in Q3 2025.
• The 5-year median for Asset Utilization Ratio is 0.08 (2022), against an average of 0.15.
• The widest annual swing landed in 2022, when Asset Utilization Ratio jumped 739.91%; it then plunged 98.76% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then jumped by 739.91% to 0.52 in 2022, then slumped by 85.17% to 0.08 in 2023, then sank by 95.38% to 0.0 in 2024, then increased by 16.96% to 0.0 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q4 2024), per Business Quant data.

Peer Comparison